Lazada Urged to Remove Unregistered E-Cigarettes in Philippines

Mar.16.2023
Lazada Urged to Remove Unregistered E-Cigarettes in Philippines
Lazada urged to remove unregistered e-cigarettes from its platform, similar to Shopee, in compliance with Philippine e-cigarette regulations.

The Philippine E-Cigarette Industry Association (PECIA) and the Philippine Nicotine Consumers Union (NCUP) are urging Lazada to follow in the footsteps of Shopee and remove unregistered e-cigarette products in compliance with the country's Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), which will take effect on July 25, 2022.


The bill covers electronic cigarette products, e-cigarette juices, e-cigarette devices, heated tobacco products, HTP consumables and devices, and new tobacco products. With the IRR set to take effect on December 28, 2022, all prohibited items under RA 11900 will no longer be sold in online and offline retail markets.


Joey Dulay, the president of PECIA, has stated that Lazada, being one of the most popular online markets, should ensure consumer welfare and protect them from unregistered and substandard products that may cause harm.


The Ministry of Industry has stated unequivocally that Lazada is responsible for complying with e-cigarette-related legislation. Shopee is a platform similar in size to Lazada, and has taken down more than one million unregistered e-cigarette listings from its website. Lazada should also take this issue seriously.


In January of this year, NCUP wrote separate letters to Shopee and Lazada, commending Shopee for taking swift and decisive action against illegal electronic cigarette products, and strongly encouraging Lazada to follow the example set by its competitor.


These platforms have a huge influence on consumers. If they see it on websites, they will think it is safe. Lazada plays a crucial role in preventing the consumption of illegal products. There are now appropriate laws to regulate electronic cigarettes, but if the platform itself does not comply, the law cannot be enforced," said NCUP President Anton Israel in the letter.


On March 1st, representatives from electronic commerce platforms met with the Department of Trade and Industry (DTI) through the Consumer Protection Group (CPG) to address the issue of banned nicotine and non-nicotine vaping products being advertised and sold online despite ongoing monitoring and law enforcement efforts.


On March 1, 2022, the Department of Trade and Industry (DTI) of the Philippines held a meeting with representatives from e-commerce platforms through the Consumer Protection Group (CPG) to address the issue of prohibiting the sale of illegal e-cigarettes online.


One day after the dialogue, Shopee reported that it had removed over one million illegal listings of electronic cigarettes from its platform. It also pledged to strengthen its monitoring of illegal electronic cigarette products and commit to continued cooperation with the trade organization.


Under RA 11900, only electronic cigarette products, devices, and new tobacco products that are registered and certified by the Philippines' Bureau of Standards (BPS) and accompanied by appropriate health warnings can be sold to the public by June 2024.


PECIA is the largest trade organization for electronic cigarettes in the Philippines, with over 200 member shop owners, suppliers, and manufacturers, as well as more than 8,000 E-cigarette alliances, representing over one million smokeless product consumers in the Philippines.


NCUP is a non-profit national advocacy organization that believes the rights and interests of millions of smokers and electronic cigarette users in the Philippines need to be protected from the influence of untested, unregulated, and unregistered products.


Reference:


Lazada has been requested to take down illegal vaping products from its online marketplace.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Germany Seizes 56 Pallets of Illegal Vapes, Probe Estimates €1.8 Million Tax Loss
Germany Seizes 56 Pallets of Illegal Vapes, Probe Estimates €1.8 Million Tax Loss
German authorities have seized dozens of pallets of illegal disposable vapes in a criminal investigation, with the products estimated to have caused at least €1.8 million in tax losses. The case has also raised concerns over cross-border supply chains linked to unauthorized nicotine products entering the European market.
Jul.14
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
A Quebec Superior Court has allowed a class action lawsuit against Juul Labs and Altria Group related to vaping products to proceed, involving allegations concerning marketing practices, youth exposure and corporate responsibility. The ruling only allows the case to move forward and does not represent a finding that Juul or Altria are legally liable. The case highlights continued legal risks facing vape companies regarding product marketing, youth protection and corporate accountability.
Jul.28
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10